Evaluation of subclinical left ventricular systolic dysfunction in obese patients by global myocardial work

Table 1 Clinical parameters of normal controls and obese patients

Clinical parameters	Normal controls (n = 100)	Obesity (n = 589)	P value
Age, year	32.28 ± 7.05	31.54 ± 7.60	0.361
Male, n (%)	35(35)	153(26)	0.061
Height, cm	165.64 ± 8.37	167.13 ± 8.01	0.089
Weight, kg	62.94 ± 11.52	105.4 ± 20.71	< 0.001
BMI, kg/m²	22.80 ± 2.79	37.53 ± 5.40	< 0.001
BSA, m²	1.66 ± 0.19	2.22 ± 0.30	< 0.001
SBP, mmHg	120.64 ± 10.96	133.48 ± 16.87	< 0.001
DBP, mmHg	76.07 ± 7.91	87.18 ± 12.06	< 0.001
h, bpm	74.00(73.13,77.49)	80.00(80.17,82.29)	< 0.001
FPG, mmol/L	4.95(4.68,5.08)	5.69(6.34,6.74)	< 0.001
HbA1c, %	5.34 ± 0.40	6.24 ± 1.33	0.002
TC, mmol/L	4.40 ± 0.85	4.84 ± 0.96	0.013
TG, mmol/L	1.06(0.97,1.30)	1.66(1.97,2.31)	0.012
HDL-C, mmol/L	1.28 ± 0.23	1.13 ± 0.48	0.003
LDL-C, mmol/L	2.62 ± 0.85	3.16 ± 0.78	< 0.001
BUN, mmol/L	4.65(3.89,4.89)	4.60(4.59,4.77)	0.311
SCR, μmol/L	59.00(55.30,68.01)	58.00(58.86,63.23)	0.565
Complications, %
Hypertension	0	120(20)
T2DM	0	242(41)

BMI: body mass index, BSA: body surface area, SBP: systolic blood pressure, DBP: diastolic blood pressure. HR: heart rate, FPG: fasting plasma glucose, HbA1c: glycated haemoglobin, TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein, LDL-C: low-density lipoprotein, BUN: blood urea nitrogen, SCR: serum creatinine

ISSN: 1758-5996